Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
11
NMPA:11
Drug Approvals
Bromhexine Hydrochloride Oral Solution
- Product Name
- 盐酸溴己新口服溶液
- Approval Number
- 国药准字H20253024
- Approval Date
- Jan 2, 2025
NMPA
Bromhexine Hydrochloride Oral Solution
- Product Name
- 盐酸溴己新口服溶液
- Approval Number
- 国药准字H20249807
- Approval Date
- Dec 25, 2024
NMPA
Ursodeoxycholic Acid Capsules
- Product Name
- 熊去氧胆酸胶囊
- Approval Number
- 国药准字H20249197
- Approval Date
- Oct 29, 2024
NMPA
Acetylcysteine Granules
- Product Name
- 乙酰半胱氨酸颗粒
- Approval Number
- 国药准字H20244740
- Approval Date
- Aug 27, 2024
NMPA
Hydrotalcite Chewable Tablets
- Product Name
- 铝碳酸镁咀嚼片
- Approval Number
- 国药准字H20244186
- Approval Date
- Jun 28, 2024
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20243338
- Approval Date
- Mar 12, 2024
NMPA
Calcium Carbonate and Vitamin D3 Granules
- Product Name
- 小儿碳酸钙D3颗粒
- Approval Number
- 国药准字H20183408
- Approval Date
- Apr 18, 2023
NMPA
Calcium Carbonate and Vitamin D3 Chewable Tablets（Ⅱ）
- Product Name
- 碳酸钙D3咀嚼片(Ⅱ)
- Approval Number
- 国药准字H20183383
- Approval Date
- Mar 10, 2023
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20103773
- Approval Date
- Sep 1, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found